NCT03303833Recruiting
The GEOLynch Cohort Study
The GEOLynch Cohort Study: Genetic, Environmental and Other Factors That Influence Tumour Risk Among Persons With Lynch Syndrome
Source: ClinicalTrials.gov · Last updated 6 Oct 2017 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The GEOLynch cohort study has been established to investigate the influence of genetic, environmental and other factors on tumour risk in persons with Lynch syndrome.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 14 Sept 2017
- Start date
- 1 Jul 2006
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- Wageningen University
- Diseases
- Colorectal cancer
- NCT number
- NCT03303833
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Jul 2006 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Additional carrier of another hereditary colon cancer predisposition syndrome (e.g. FAP)
- (Chronic) Inflammatory bowel disease
- Dementia or another mental condition that makes it impossible to fill out questionnaires
Other
- Non-Dutch speaking
- Terminally ill persons
Who the study is looking for
- Persons with a known mutation in a gene that causes Lynch syndrome, i.e. with an inherited monoallelic pathogenic germline mutation in either the MLH1, MSH2, MSH6, PMS2 or EPCAM gene.
- Aged between 18 and 80 years at inclusion.
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Wageningen University Coordinator of this site? Confirm its status | Wageningen | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.